Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease

Journal of Allergy and Clinical Immunology

Volumn 129, Issue 1, 2012, Pages 176-183

  Martinez, Caridad A ^a   Shah, Sweta ^a   Shearer, William T ^a   Rosenblatt, Howard M ^b   Paul, Mary E ^a   Chinen, Javier ^a   Leung, Kathryn S ^a   Kennedy Nasser, Alana ^a   Brenner, Malcolm K ^a   Heslop, Helen E ^a   Liu, Hao ^c   Wu, Meng Fen ^c   Hanson, Imelda C ^a   Krance, Robert A ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b DELL INC   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

bone marrow transplantation; Chronic granulomatous disease; graft versus host disease; primary immunodeficiencies

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ECHINOCANDIN; FLUDARABINE; IMIDAZOLE; METHOTREXATE; PREDNISONE;

ADOLESCENT; ARTICLE; ASPERGILLOSIS; ASYMPTOMATIC INFECTION; AUTOSOMAL RECESSIVE DISORDER; CANCER SURVIVAL; CHILD; CHRONIC GRANULOMATOUS DISEASE; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; INFANT; MALE; NEUTROPHIL; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; SCHOOL CHILD; SEIZURE; STEM CELL TRANSPLANTATION;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; CHILD; CHILD, PRESCHOOL; EDUCATIONAL STATUS; FEMALE; GRAFT VS HOST DISEASE; GRANULOMATOUS DISEASE, CHRONIC; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; QUALITY OF LIFE; SIBLING RELATIONS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; UNRELATED DONORS;

EID: 84455205615     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.10.005     Document Type: Article

References (29)

1. J. Merlijn van den Berg, E. van Doppen, A. Ahlin, B. Belohradsky, E. Bernatowska, and L. Corbeel Chronic granulomatous disease: the European experience PloS ONE 4 2009 1 10
2. E.M. Kang, B.E. Marciano, S. DeRavin, K. Zarember, S. Holland, and H.L. Malech Chronic granulomatous disease: overview and hematopoietic stem cell transplantation J Allergy Clin Immunol 127 2011 1319 1326
3. J. Liese, S. Kloos, V. Jendrossek, T. Petropoulou, U. Wintergerst, and G. Notheis Long-term follow-up and outcome of 39 patients with chronic granulomatous disease J Pediatr 137 2000 687 693
4. B. Martire, R. Rondelli, A. Soresina, C. Pignata, T. Broccoletti, and A. Finocchi Clinical features, long-term follow up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study Clin Immunol 126 2008 155 164
5. R. Jones, P. McGrogan, T. Flood, A.R. Gennery, L. Morton, and A. Thrasher Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry Clin Exp Immunol 152 2008 211 218
6. J.A. Winkesltein, M.C. Marino, R.B. Johnston, J. Boyle, J. Curnutte, and J. Gallin Chronic granulomatous disease: report on a national registry of 368 patients Medicine 79 2000 155 169
7. The International Chronic Granulomatous Disease Cooperative Study Group A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease N Engl J Med 324 1991 509 516
8. D.M. Margolis, D.A. Melnick, D.W. Alling, and J.I. Gallin Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease J Infect Dis 162 1990 723 726
9. R.S. Weening, P. Kabel, P. Pijman, and D. Roos Continuous therapy with sulfamethoxasole-trimethoprim in patients with chronic granulomatous disease J Pediatr 103 1982 127 130
10. J. Gallin, D. Alling, H. Malech, R. Wesley, D. Koziol, and B. Marciano Itraconazole to prevent fungal infections in chronic granulomatous disease N Engl J Med 348 2003 2416 2422
11. A. Fischer, P. Landais, W. Friedrich, G. Morgan, B. Gerritsen, and A. Fasth European experience of bone marrow transplantation for severe combined immunodeficiency Lancet 336 1990 850 854
12. W. Qasim, M. Cavazzana-Calvo, G. Davies, J. Davis, M. Duval, and G. Eames Allogeneic hematopoietic stem cell transplantation for leukocyte adhesion deficiency Pediatrics 123 2008 836 840
13. A. Gennery, M. Slatter, L. Grandin, P. Taupin, A. Cant, and P. Veys Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol 126 2010 602 610 e11
14. E. Grunebaum, E. Mazzolari, F. Porta, D. Dallera, A. Atkinson, and B. Reid Bone marrow transplantation for severe combined immune deficiency JAMA 295 2006 508 518
15. E. Soncini, M. Slatter, L.B. Jones, S. Hughes, T. Flood, and D. Barge Unrelated donor and HLA-identical sibling haemotopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth Br J Haematol 145 2009 73 83
16. R.A. Seger Modern management of chronic granulomatous disease Br J Haematol 140 2008 225 266
17. T.A. Fleisher, and J.B. Oliveira Functional and molecular evaluation of lymphocytes J Allergy Clin Immunol 114 2004 227 234
18. J. Pinheiro, and D. Bates Mixed-effects models in S and S-PLUS 2009 Springer Berlin
19. W.T. Shearer, H.M. Rosenblatt, R. Gelman, R. Oyomopito, S. Plaeger, and R. Stiehm Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trial Group P1009 study J Allergy Clin Immunol 112 2003 973 980
20. H.L. Malech, P.B. Maples, N. Whiting-Theobald, G.F. Linton, S. Sekhsaria, and S.J. Vowells Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease Proc Natl Acad Sci U S A 94 1997 12133 12138
21. S. Stein, M. Ott, S. Schultze-Strasser, A. Jauch, B. Burwinkle, and A. Kinner Genomic Instability and myelodysplasia with monosomy 7 consequent to EVI 1 activation after gene therapy for chronic granulomatous disease Nat Med 16 2010 198 204
22. R. Seger, T. Gungor, B. Belohradsky, S. Blanche, P. Bordigoni, and S. Blance Treatment of chronic granulomatous disease with myeloblative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000 Blood 100 2002 4344 4350
23. C. Shuetz, M. Hoenig, S. Gatz, F. Specth, U. Benninghoff, and A. Shulz Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease Immunol Res 44 2009 35 41
24. G. Hale, P. Jacobs, L. Wood, W.E. Fibbe, R. Barge, and N. Novitzky CD 52 Antibodies for prevention of graft vs. host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells Bone Marrow Transplant 26 2000 69 76
25. A.J. Shah, N. Kapoor, G. Crooks, K. Weinsberg, A. Hisham, and R. Killen The effects of Campath 1H upon graft-versus-host disease, infection, relapse, and immune reconstitution in recipients of pediatric unrelated transplants Biol Blood Marrow Transplant 13 2007 584 593
26. S. Chakrabarti, S. Mackinnon, R. Chopra, D. Kottaridis, K. Peggs, and P. O'Gorman High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution Blood 99 2002 4357 4363
27. A. Kennedy-Nasser, K. Leung, C. Martinez, M. Brenner, H. Heslop, and R.A. Krance Haploidentical stem cell transplants in children with acute lymphoblastic leukemia in first and second remission Biol Blood Marrow Transplant 17 Suppl 2011 S310 S311
28. H.E. Heslop, K.S. Slobod, M.A. Pule, G. Hale, A. Rousseau, and C. Smith Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients Blood 115 2010 925 935
29. A.M. Leen, G.D. Myers, U. Sili, H. Huls, H. Weiss, and K.S. Leung Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals Nat Med 12 2006 1160 1166